The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
February 1st 2025
Fitusiran is part of a generation of novel RNA interference therapies and is designed for subcutaneous administration for the prophylactic treatment of hemophilia A or B.
January 31st 2025
Hyperkalemia Treatment May Require New Dosing Instructions
October 26th 2015The FDA is requiring Concordia Pharmaceuticals to conduct studies on its hyperkalemia treatment, sodium polystyrene sulfonate (Kayexalate), to see if it binds to other medications administered by mouth, which would decrease potency.
Read More